Internal Medicine Government Medical College Srinagar, Srinagar, India.
Curr Rheumatol Rev. 2024;20(5):569-573. doi: 10.2174/0115733971263972231124111042.
Mixed connective tissue disease (MCTD) is defined as a systemic rheumatic disease characterized by the presence of high titer anti-U1 ribonucleoprotein (U1 RNP) antibodies in combination with clinical features commonly seen in systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA) and polymyositis (PM).
The annual incidence of MCTD is 1.9 per 100,000 adults. Any organ system can be involved in MCTD however four clinical features that suggest the presence of MCTD rather than another systemic rheumatic disease are Raynaud phenomenon with swollen hands or puffy fingers, absence of severe kidney disease and central nervous system (CNS) disease at first presentation generally, insidious onset of pulmonary hypertension and presence of autoantibodies anti-U1 ribonucleoprotein (U1 RNP), especially antibodies to the 68 kD protein. MCTD, although initially thought to be a disease with a benign course is not considered a valid argument at present. This connective tissue disorder can present with life-threating organ involvement with rapid progression of disease.
We report two cases of MCTD, one with mild disease and another with life-threatening illness, describing the range of severity at presentation of this disorder.
混合性结缔组织病(MCTD)定义为一种系统性风湿病,其特征是存在高滴度的抗 U1 核糖核蛋白(U1 RNP)抗体,结合常见于系统性红斑狼疮(SLE)、系统性硬皮病(SSc)、类风湿关节炎(RA)和多发性肌炎(PM)的临床特征。
MCTD 的年发病率为每 10 万人中有 1.9 例。任何器官系统都可能受到影响,但存在以下四个临床特征提示存在 MCTD,而不是其他系统性风湿病:雷诺现象伴手部肿胀或手指肿胀、初次就诊时无严重肾脏疾病和中枢神经系统(CNS)疾病、肺动脉高压的隐匿性发作以及存在抗 U1 核糖核蛋白(U1 RNP)的自身抗体,尤其是抗 68 kD 蛋白的抗体。尽管最初认为 MCTD 是一种良性病程的疾病,但目前并不认为其具有正当理由。这种结缔组织疾病可导致危及生命的器官受累,疾病迅速进展。
我们报告了两例 MCTD 病例,一例病情较轻,另一例病情危及生命,描述了这种疾病发病时的严重程度范围。